Postmarket Requirements Will Be "Studies" Unless "Trials" Are Needed - FDA

FDA's 1draft guidance on how it will implement the authority under the FDA Amendments Act to require postmarketing research activities by sponsors defines a difference between "studies" and "clinical trials," although apparently somewhat grudgingly